National University of Singapore (NUS)

The deep space quantum link: prospective fundamental physics experiments using long-baseline quantum optics (2022) Mohageg M, Mazzarella L, Anastopoulos C, Gallicchio J, Hu BL, Jennewein T, Johnson S, et al. Journal article, Review article Global Matrix 4.0 Physical Activity Report Card Grades for Children and Adolescents: Results and Analyses From 57 Countries (2022) Aubert S, Barnes JD, Demchenko I, Hawthorne M, Abdeta C, Nader PA, Sala JCA, et al. Journal article Neoadjuvant pembrolizumab plus chemotherapy versus placebo plus chemotherapy, followed by adjuvant pembrolizumab versus placebo for early-stage TNBC: Event-free survival sensitivity and subgroup analyses from KEYNOTE-522 (2022) Schmid P, Cortes J, Dent R, Pusztai L, Mcarthur H, Kuemmel S, Bergh J, et al. Conference contribution Contributions of renal water loss and skin water conservation to blood pressure elevation in spontaneously hypertensive rats (2022) Ogura T, Kitada K, Morisawa N, Fujisawa Y, Kidoguchi S, Nakano D, Kobara H, et al. Journal article Incorporating progesterone receptor expression into the PREDICT breast prognostic model (2022) Grootes I, Keeman R, Blows FM, Milne RL, Giles GG, Swerdlow AJ, Fasching PA, et al. Journal article Association of bronchial steroid inducible methylation quantitative trait loci with asthma and chronic obstructive pulmonary disease treatment response (2022) Slob EMA, Faiz A, Van Nijnatten J, Vijverberg SJH, Longo C, Kutlu M, Chew FT, et al. Journal article Kyoto international consensus report on anatomy, pathophysiology and clinical significance of the gastro-oesophageal junction (2022) Sugano K, Spechler SJ, El-Omar EM, Mccoll KEL, Takubo K, Gotoda T, Fujishiro M, et al. Journal article, Review article Perspectives on the Risk-Stratified Treatment of Multiple Myeloma (2022) Davies FE, Pawlyn C, Usmani SZ, San-Miguel JF, Einsele H, Boyle EM, Corre J, et al. Journal article Breast cancer risks associated with missense variants in breast cancer susceptibility genes (2022) Dorling L, Carvalho S, Allen J, Parsons MT, Fortuno C, Gonzalez-Neira A, Heijl SM, et al. Journal article KEYNOTE-522: Neoadjuvant Pembrolizumab plus Chemotherapy vs Placebo plus Chemotherapy Followed by Adjuvant Pembrolizumab vs Placebo for Early-stage Triple Negative Breast Cancer (2022) Mcarthur H, Cortes J, Dent R, Pusztai L, Kuemmel S, Bergh J, Denkert C, et al. Conference contribution